NASDAQ: GRCE
Grace Therapeutics Inc Stock Ownership - Who owns Grace Therapeutics?

Insider buying vs selling

Have Grace Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Prashant KohliCEO2026-09-09100,000$2.14
$214.00kBuy
Opaleye Management Inc10% Owner2026-09-095,836$2.09
$12.20kBuy
Opaleye Management Inc10% Owner2026-09-089,393$2.10
$19.70kBuy
Opaleye Management Inc10% Owner2026-08-1411,608$2.09
$24.20kBuy

1 of 1

GRCE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GRCE insiders and whales buy or sell their stock.

GRCE Shareholders

What type of owners hold Grace Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Grace 2018 Irrevocable Trust Rajitha22.29%4,689,547$10.74MInsider
Opaleye Management Inc13.19%2,775,229$6.36MInsider
Adar1 Capital Management LLC4.56%959,571$2.20MInsider
George Kottayil2.35%494,698$1.13MInsider
William A. Haseltine1.58%332,836$762.19kInsider
Vimal Kavuru0.59%124,344$284.75kInsider
Prashant Kohli0.58%121,357$277.91kInsider
John Canan0.48%100,000$229.00kInsider
Amresh Kumar0.32%66,712$152.77kInsider
Janelle Dalvise0.25%52,500$120.23kInsider

1 of 3

GRCE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GRCE0.02%46.64%Net BuyingNet Buying
HOWL0.02%83.87%Net SellingNet Selling
ANVS0.03%12.34%Net Buying
MCRB0.00%100.00%Net SellingNet Selling
MREO0.01%4.17%

Grace Therapeutics Stock Ownership FAQ

Who owns Grace Therapeutics?

Grace Therapeutics (NASDAQ: GRCE) is owned by 0.02% institutional shareholders, 46.64% Grace Therapeutics insiders, and 53.34% retail investors. Grace 2018 Irrevocable Trust Rajitha is the largest individual Grace Therapeutics shareholder, owning 4.69M shares representing 22.29% of the company. Grace 2018 Irrevocable Trust Rajitha's Grace Therapeutics shares are currently valued at $10.46M.

If you're new to stock investing, here's how to buy Grace Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.